Faculty Disclosures

Article Outline

 

The authors who contributed to this publication have disclosed the following industry relationships:

David R. Johnson, MD, MPH, is a full-time employee of Sanofi Pasteur Inc.

Kim Lipczynski, PhD, is a full-time employee of Adelphi Research by Design; and has served as a consultant to Sanofi Pasteur Inc.

Kristin L. Nichol, MD, MPH, has served as a consultant to Sanofi Pasteur Inc., MedImmune, Novartis, GlaxoSmithKline, and CSL Biotherapies; and received research funding from GlaxoSmithKline and Sanofi Pasteur Inc.

Walter A. Orenstein, MD, has received grant support for clinical trials and research from Merck & Co., Sanofi Pasteur Inc. and Novartis; and serves on two data safety monitoring boards for clinical vaccine trials, Encorium (formerly Dynport) for bioterrorism threats and GlaxoSmithKline for pneumococcal vaccine.

Gregory A. Poland, MD, provided consulting advice and/or performed clinical research trials for Novavax, Merck & Co., Protein Science, GlaxoSmithKline, Novartis Vaccines, CSL Limited, PowderMed, and Avianax.

William Schaffner, MD, serves as a consultant to GlaxoSmithKline, MedImmune, Merck & Co., Novartis, Sanofi Pasteur Inc. and Wyeth Pharmaceuticals; and is a member of a data safety evaluation committee for experimental vaccines for Merck & Co.

Patricia K. Stinchfield, RN, MS, CPNP, has no financial arrangement or affiliation with a corporate organization or a manufacturer of a product discussed in this supplement. She currently serves as a voting member on the Advisory Committee on Immunization Practices for the Centers for Disease Control and Prevention.